Article Abstract

Liquid biopsy-based biomarkers for early detection of pancreatic cancer

Authors: Johannes F. Fahrmann, Michela Capello, Samir Hanash


Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer-related mortality in both men and women in the United States (1). Alarmingly, the incidence of PDAC-related mortality continues to rise and PDAC is projected to be the second deadliest cancer in the U.S. by 2030 (2).